Liu Kuang-Ting, Chang Yueh-Ching, Lin Yu-Chieh, Chang Junn-Liang
Department of Pathology and Laboratory Medicine, Taoyuan Armed Forces General Hospital.
Hsin Sheng Junior College of Medical Care and Management.
Ann Med Surg (Lond). 2023 Apr 11;85(5):1978-1982. doi: 10.1097/MS9.0000000000000515. eCollection 2023 May.
Primary non-Hodgkin's lymphoma of the gastrointestinal (GI) tract is rare. It is aggressive and necessitates early diagnosis and management. Simultaneous primary GI lymphomas are unusual with rarely reported cases.
This novel case report describes an 84-year-old man with multiple primary diffuse large B-cell lymphomas (DLBCLs) of the jejunum with disseminating pleural and multiple regional lymph nodes involvement presenting as intestinal obstruction and segments of jejunojejunal intussusception. The patient underwent surgical intervention and adjuvant chemotherapy. Unfortunately, the patient suffered from multiple organ failure and died 4 months after surgery.
Obstruction and perforation are rare and life-threatening complications of GI lymphoma. Multiple DLBCLs of the jejunum are rare. Moreover, primary GI-DLBCL that initially presents with pleural effusion or with intestinal perforation is uncommon. This report aims to remind clinicians that lymphoma should be considered when assessing the cause of unexplained pleural effusion, especially when the available examination data cannot be confirmed by clinical manifestations.
Through this case report, the authors learn that clinical manifestations, morphological characteristics, immunophenotypes, and molecular biological characteristics are vastly different and important. This poses the biggest challenge before surgery and should not be ignored.
胃肠道原发性非霍奇金淋巴瘤罕见。它具有侵袭性,需要早期诊断和治疗。同时发生的原发性胃肠道淋巴瘤不常见,报道的病例很少。
本病例报告描述了一名84岁男性,患有空肠多发性原发性弥漫性大B细胞淋巴瘤(DLBCL),伴有胸膜播散和多个区域淋巴结受累,表现为肠梗阻和空肠空肠套叠节段。患者接受了手术干预和辅助化疗。不幸的是,患者术后出现多器官功能衰竭,术后4个月死亡。
梗阻和穿孔是胃肠道淋巴瘤罕见且危及生命的并发症。空肠多发性DLBCL罕见。此外,最初表现为胸腔积液或肠穿孔的原发性胃肠道DLBCL并不常见。本报告旨在提醒临床医生,在评估不明原因胸腔积液的病因时应考虑淋巴瘤,尤其是当现有检查数据无法通过临床表现证实时。
通过本病例报告,作者了解到临床表现、形态学特征、免疫表型和分子生物学特征差异很大且很重要。这在手术前构成了最大的挑战,不容忽视。